Blog

  • Genome editing: Key Stakeholders within TALEN

    We follow-up our previous post on CRISPR with an analysis of the stakeholder landscape within the competing/complementary genome editing technology TALEN.

    Read more
  • Identifying Rising Stars: CAR-T use case

    In this blog post, we put the recently introduced rising stars features in Monocl EGO to a test and showcase the power of a data-driven approach in stakeholder mapping.

    Read more
  • Fireside chat with Monocl CEO about the importance of rising stars and the recent release

    Watch Monocl CEO, Björn Carlsson, and Business Developer, Felix Jansson, talk about the importance of working with rising stars and the new features released in Monocl EGO.  

    Read more
  • A new approach to Rising Stars

    The competition to work with opinion leaders is fierce, making it paramount to establish a close relationship with rising stars as early as possible. We are today introducing a set of groundbreaking features designed to help you find and characterize emerging opinion leaders. Watch Monocl CEO Björn Carlsson share a few words on why it has become increasingly important to work with

    Read more
  • Genome editing: Who’s who within CRISPR?

    This week we focus on the genome editing technology CRISPR. The leading experts, rising stars and main indications all outlined in this week’s post of through the lens – stakeholder insights brought to you by Monocl.

    Read more
  • The key CTLA-4 stakeholders you should be working with

    Your weekly stakeholder insights, brought to you by Monocl. In this second part of our Immuno-Oncology analysis, we focus on key stakeholder with experience in the immune checkpoint inhibitor CTLA-4. Here we outline the both established opinion leaders as well as rising stars in the space.

    Read more
  • The rising stars, key opinion leaders and top sponsor within Immuno-Oncology

    This week’s issue of ‘through the lens’ features the key opinion leaders, rising stars and top institutions you should have on your radar. In addition, we look into the clinical trials trend, the top sponsors and the major indications in the immuno-oncology space.

    Read more
  • The key stakeholders and trends within Next Generation Sequencing

    The leading experts, institutions and trending application areas within Next Generation Sequencing. Your weekly stakeholder insights brought to you by Monocl

    Read more
  • 3 ways to boost Marketing and Medical Affairs with artificial intelligence

    The rapid pace at which the world of life sciences is moving and evolving is driving the production of increasingly diverse and unstructured data. As a result, the number of sources and the volume of accessible data is expanding, fast. However, we would argue that the internal capabilities to make sense of it – the process of transforming it into

    Read more
  • The key stakeholders and trends within NASH

    Introducing ‘through the lens’ – a weekly newsletter from Monocl in which we provide relevant and readily digestible stakeholder and landscape insights in a range of different areas of life science. In this premiere, we outline the top experts, institutions as well as top sponsors and trends within NASH.

    Read more
  • Shedding light on the CAR-T space – research, clinical activity and targets of interest

    To many, the state of the CAR-T landscape is shrouded in mystery. Which targets – other than CD19 – are experts in the field investing time and resources in? Which indications are CAR-T expert most frequently evaluating and where is the most cutting-edge research being performed? In this blog post, we try to shed light on a few of these questions.

    Read more
  • Monocl CEO talks about the new release

    Watch Monocl CEO Björn Carlsson talk about the new release of Monocl EGO and how Monocl will carry the excellent momentum into next year.

    Read more
  • How to make the most out of the new Monocl EGO

    With the new release made today, you are able to search directly for publications, clinical trials and grant payments. This post covers some interesting new use cases that you likely will be interested in exploring.

    Read more
  • Meet the new Monocl EGO!

    We are today launching a brand new version of Monocl EGO! We have created a whole new interface, built new modules and added hundreds of new features to truly transform your workflow and drive operational efficiency. We want you to be at least one step ahead of your competition – every single time.

    Read more
  • Win an annual subscription of Monocl EGO! Register for Monocl’s Christmas Raffle

    We are incredibly excited about what we have in store for you this week. We are now in the process of making the final touches on our greatest update since launch – a new version of Monocl EGO. To celebrate, we are handing out two annual subscriptions of the new Monocl EGO. Register for the Christmas Raffle to win a subscription!

    Read more
Load More